Governor announces proposed regulations for cannabinoid hemp products in NY
NYS Department of Health will license processors and retailers, set quality control standards
Press Release, Gov. Andrew Cuomo’s Office
Governor Andrew M. Cuomo today announced that the New York State Department of Health has filed proposed regulations to regulate cannabinoid hemp products in New York State.
In accordance with legislation signed earlier this year by the Governor, the Department is creating a Cannabinoid Hemp Program. The Program will license both cannabinoid hemp processors and retailers and set quality control standards that all cannabinoid hemp products must meet.
“These regulations are the next step toward regulating the growing hemp industry in New York in a way that protects consumers and helps ensure the industry’s long-term viability,” said Governor Cuomo. “Establishing the State’s Cannabinoid Hemp Program to regulate production and sale of hemp and hemp extract will help protect both consumers and farmers.”
The Cannabinoid Hemp Program will organize and legitimize the cannabinoid market in New York State by creating a licensing framework for cannabinoid hemp processors and retailers, and by establishing basic manufacturing, packaging and labeling and laboratory testing standards. Currently, applications for cannabinoid hemp processing and retailing licenses are under development, and NYSDOH intends to make them available in early 2021.
In 2015, the Governor launched the Industrial Hemp Agricultural Research Pilot Program, supporting farmers and further boosting economic development in upstate New York. Since then, New York’s hemp program has expanded significantly, making New York one of the leading hemp producing states in the country, with more than 700 farmers and 100 manufacturers of hemp products.
Hemp is a sustainable, carbon-sequestering crop that is capable of being transformed into hundreds of products including textiles, furniture, fuel, food, construction materials and personal care items.
Some hemp products that have been growing in popularity include cannabinoid hemp products such as Cannabidiol, or CBD, which can be found online or in retail stores throughout the state. While regulations exist at the federal level for the growth of hemp, there are currently no federal regulations for the processing and manufacturing of cannabinoid hemp products, resulting in the cannabinoid hemp marketplace lacking basic consumer protections that are common in similar industries.
There are published reports of cannabinoid hemp products that do not contain any cannabinoids but contain unspecified or inconsistent levels of THC – the psychoactive component of the cannabis plant – or are contaminated with harmful toxins.
The proposed regulations fill this regulatory void and create a system allowing for the use of hemp-derived cannabinoids in certain foods, beverages, topicals and dietary supplement products, provided regulatory requirements are satisfied.
All cannabinoid hemp products must be manufactured using good manufacturing practices based on the end product’s intended use. The label must contain the total amount of cannabinoids in the product, number of cannabinoids per serving, a nutritional or supplement fact panel, information about whether the product contains THC and appropriate warnings stating the product is not intended for children, its use may cause the failure of a drug test, the product has not been evaluated by the FDA and if pregnant or nursing, to consult a healthcare provider before use.
Additionally, cannabinoid hemp products are required to be laboratory-tested before entering the market, with testing for their cannabinoid profile, heavy metals, microbial impurities, mycotoxins, pesticides and residual solvents. This information is required to be retrievable by the consumer in the form of a QR code or corresponding link on the product label.
Retailers are prohibited from selling inhalable cannabinoid hemp products, such as vape products, to consumers under 21 years of age. Processors are prohibited from making claims suggesting the product will diagnose, cure, mitigate, treat or prevent disease.
“When you purchase a product, you should have confidence that what is stated on the label is actually in the product,” said New York State Department of Health Commissioner Dr. Howard Zucker. “With the increased production and use of cannabinoid hemp products, New York State could not wait for the federal government to act to institute basic consumer protections to protect the health and safety of New Yorkers.”
For more information on New York’s Cannabinoid Hemp Program and to view the proposed regulations, click here.